About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 612316, 18 pages
http://dx.doi.org/10.1155/2012/612316
Review Article

Rabbit and Mouse Models of HSV-1 Latency, Reactivation, and Recurrent Eye Diseases

1Department of Ophthalmology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA
2Department of Pharmacology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA
3Department of Microbiology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA
4Neuroscience Center, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA
5College of Science and Engineering, Tulane University, New Orleans, LA 70118, USA
6Department of Biology, Xavier University of Louisiana, One Drexel Drive, New Orleans, LA 70125, USA
7School of Pharmacy and Health Professions, University of Maryland Eastern Shore, Princess Anne, MD 21853, USA
8Department of Genetics, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA
9Department of Biostatistics, Louisiana State University Health Sciences Center School of Public Health, New Orleans, LA 70112, USA

Received 6 January 2012; Revised 4 May 2012; Accepted 22 May 2012

Academic Editor: Andre Van Wijnen

Copyright © 2012 Jody M. Webre et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. J. Al-Dujaili, P. P. Clerkin, C. Clement et al., “Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?” Future Microbiology, vol. 6, no. 8, pp. 877–907, 2011. View at Publisher · View at Google Scholar
  2. H. S. Toma, A. T. Murina, R. G. Areaux Jr. et al., “Ocular HSV-1 latency, reactivation and recurrent disease,” Seminars in Ophthalmology, vol. 23, no. 4, pp. 249–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. E. R. Richter, J. K. Dias, J. E. Gilbert, and S. S. Atherton, “Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck,” Journal of Infectious Diseases, vol. 200, no. 12, pp. 1901–1906, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Bustos and S. S. Atherton, “Detection of herpes simplex virus type 1 in human ciliary ganglia,” Investigative Ophthalmology & Visual Science, vol. 43, no. 7, pp. 2244–2249, 2002. View at Scopus
  5. Y. Shimomura, J. B. Dudley, L. P. Gongarosa, and J. M. Hill, “HSV-1 quantitation from rabbit neural tissues after epinephrine-induced reactivation,” Investigative Ophthalmology & Visual Science, vol. 26, no. 1, pp. 121–125, 1985. View at Scopus
  6. Y. Yamamoto and J. M. Hill, “HSV-1 recovery from ocular tissues after viral inoculation into the superior cervical ganglion,” Investigative Ophthalmology & Visual Science, vol. 27, no. 10, pp. 1447–1452, 1986. View at Scopus
  7. D. P. Kennedy, C. Clement, R. L. Arceneaux, P. S. Bhattacharjee, T. S. Huq, and J. M. Hill, “Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?” Cornea, vol. 30, no. 3, pp. 251–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Hill, M. A. Rayfield, and Y. Haruta, “Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits,” Current Eye Research, vol. 6, no. 1, pp. 91–97, 1987. View at Scopus
  9. B. S. Kwon, L. P. Gangarosa, K. D. Burch, J. deBack, and J. M. Hill, “Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea,” Investigative Ophthalmology & Visual Science, vol. 21, no. 3, pp. 442–449, 1981. View at Scopus
  10. Y. Haruta, L. J. Maguire, D. S. Rootman, and J. M. Hill, “Recurrent herpes simplex virus type 1 corneal epithelial lesions after radial keratotomy in the rabbit,” Archives of Ophthalmology, vol. 105, no. 5, pp. 692–694, 1987. View at Scopus
  11. D. C. Bloom, G. B. Devi-Rao, J. M. Hill, J. G. Stevens, and E. K. Wagner, “Molecular analysis of herpes simplex virus type 1 during epinephrine- induced reactivation of latently infected rabbits in vivo,” Journal of Virology, vol. 68, no. 3, pp. 1283–1292, 1994. View at Scopus
  12. N. M. Sawtell, D. K. Poon, C. S. Tansky, and R. L. Thompson, “The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation,” Journal of Virology, vol. 72, no. 7, pp. 5343–5350, 1998. View at Scopus
  13. N. M. Sawtell, “Comprehensive quantification of herpes simplex virus latency at the single-cell level,” Journal of Virology, vol. 71, no. 7, pp. 5423–5431, 1997. View at Scopus
  14. N. M. Sawtell and R. L. Thompson, “Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency,” Journal of Virology, vol. 66, no. 4, pp. 2157–2169, 1992. View at Scopus
  15. Y. J. Gordon, K. A. Yates, F. S. Mah, and E. G. Romanowski, “The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models,” Journal of Ocular Pharmacology and Therapeutics, vol. 19, no. 3, pp. 233–245, 2003. View at Scopus
  16. T. P. Margolis, F. L. Elfman, D. Leib et al., “Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia,” Journal of Virology, vol. 81, no. 20, pp. 11069–11074, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. B. M. Gebhardt, E. D. Varnell, J. M. Hill, and H. E. Kaufman, “Animal models of ocular herpes simplex virus infection (rabbits, primates, mice),” in Handbook of Animal Models of Infection, O. Zak and M. Sande, Ed., pp. 919–926, Academic Press, London, UK, 1999.
  18. L. Caspary, B. Schindling, S. Dundarov, and D. Falke, “Infections of susceptible and resistant mouse strains with herpes simplex virus type 1 and 2,” Archives of Virology, vol. 65, no. 3-4, pp. 219–227, 1980. View at Scopus
  19. R. D. Stulting, J. C. Kindle, and A. J. Nahmias, “Patterns of herpes simplex keratitis in inbred mice,” Investigative Ophthalmology & Visual Science, vol. 26, no. 10, pp. 1360–1367, 1985. View at Scopus
  20. A. A. Chentoufi, G. Dasgupta, N. D. Christensen et al., “A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes,” Journal of Immunology, vol. 184, no. 5, pp. 2561–2571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. D. C. Bloom, “HSV-1 latency and the roles of the LATs,” in Alpha Herpesviruses: Molecular and Cellular Biology, R. M. Sandri-Goldin, Ed., pp. 325–342, Caister Academic Press, Norwich, UK, 2006.
  22. G. C. Perng, S. M. Slanina, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler, “The effect of latency-associated transcript on the herpes simplex virus type 1 latency-reactivation phenotype is mouse strain-dependent,” Journal of General Virology, vol. 82, no. 5, pp. 1117–1122, 2001. View at Scopus
  23. R. L. Thompson and N. M. Sawtell, “The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency,” Journal of Virology, vol. 71, no. 7, pp. 5432–5440, 1997. View at Scopus
  24. R. L. Thompson and N. M. Sawtell, “Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival,” Journal of Virology, vol. 75, no. 14, pp. 6660–6675, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. P. S. Bhattacharjee, D. M. Neumann, T. P. Foster et al., “Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1,” Experimental Eye Research, vol. 87, no. 2, pp. 122–130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Hill, P. S. Bhattacharjee, and D. M. Neumann, “Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease,” Experimental Eye Research, vol. 84, no. 5, pp. 801–811, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. Burgos, C. Ramirez, I. Sastre, M. J. Bullido, and F. Valdivieso, “Involvement of apolipoprotein E in the hematogenous route of herpes simplex virus type 1 to the central nervous system,” Journal of Virology, vol. 76, no. 23, pp. 12394–12398, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. S. Burgos, C. Ramirez, I. Sastre, M. J. Bullido, and F. Valdivieso, “ApoE4 is more efficient than E3 in brain access by herpes simplex virus type I,” NeuroReport, vol. 14, no. 14, pp. 1825–1827, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. P. S. Bhattacharjee, D. M. Neumann, D. Stark, H. W. Thompson, and J. M. Hill, “Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model,” Current Eye Research, vol. 31, no. 9, pp. 703–708, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. T. J. Hill, D. A. Harbour, and W. A. Blyth, “Isolation of herpes simplex virus from the skin of clinically normal mice during latent infection,” Journal of General Virology, vol. 47, no. 1, pp. 205–207, 1980. View at Scopus
  31. S. Z. Abghari and R. Stulting, “Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice,” Investigative Ophthalmology & Visual Science, vol. 29, no. 2, pp. 239–243, 1988. View at Scopus
  32. D. L. Easty, C. Shimeld, C. M. Claoue, and M. Menage, “Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies,” Current Eye Research, vol. 6, no. 1, pp. 69–74, 1987. View at Scopus
  33. S. J. Allen, P. Hamrah, D. Gate et al., “The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1,” Journal of Virology, vol. 85, no. 9, pp. 4184–4197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. S. J. Allen, K. R. Mott, M. Zandian, and H. Ghiasi, “Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice,” Journal of Virology, vol. 84, no. 23, pp. 12315–12324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. B. Reddy, S. Sehrawat, A. Suryawannshi et al., “Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency,” Journal of Immunology, vol. 187, no. 11, pp. 5745–5755, 2011. View at Publisher · View at Google Scholar
  36. V. D. Menachery and D. A. Leib, “Control of herpes simplex virus replication is mediated through an interferon regulatory factor 3-dependent pathway,” Journal of Virology, vol. 83, no. 23, pp. 12399–12406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. R. J. Cohrs, D. M. Koelle, M. C. Schuette et al., “Asymptomatic alphaherpesvirus reactivation,” in Herpesviridae: Viral Structure, Life Cycle and Infections, T. R. Gluckman, Ed., pp. 133–168, Nova Science, Hauppauge, NY, USA, 2009.
  38. M. Kumar, J. M. Hill, C. Clement, E. D. Varnell, H. W. Thompson, and H. E. Kaufman, “A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva,” Investigative Ophthalmology & Visual Science, vol. 50, no. 12, pp. 5601–5608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. H. E. Kaufman, A. M. Azcuy, E. D. Varnell, G. D. Sloop, H. W. Thompson, and J. M. Hill, “HSV-1 DNA in tears and saliva of normal adults,” Investigative Ophthalmology & Visual Science, vol. 46, no. 1, pp. 241–247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. E. J. Berman and J. M. Hill, “Spontaneous ocular shedding of HSV-1 in latently infected rabbits,” Investigative Ophthalmology & Visual Science, vol. 26, no. 4, pp. 587–590, 1985. View at Scopus
  41. M. Kumar, H. E. Kaufman, C. Clement et al., “Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1 DNA shedding into tears of latently infected rabbits,” Investigative Ophthalmology & Visual Science, vol. 51, no. 9, pp. 4703–4706, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Shimeld, T. J. Hill, W. A. Blyth, and D. L. Easty, “Reactivation of latent infection and induction of recurrent herpetic eye disease in mice,” Journal of General Virology, vol. 71, no. 2, pp. 397–404, 1990. View at Scopus
  43. L. T. Feldman, A. R. Ellison, C. C. Voytek, L. Yang, P. Krause, and T. P. Margolis, “Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 2, pp. 978–983, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. D. E. Willey, M. D. Trousdale, and A. B. Nesburn, “Reactivation of murine latent HSV infection by epinephrine iontophoresis,” Investigative Ophthalmology & Visual Science, vol. 25, no. 8, pp. 945–950, 1984. View at Scopus
  45. B. M. Gebhardt and J. M. Hill, “T lymphocytes in the trigeminal ganglia of rabbits during corneal HSV infection,” Investigative Ophthalmology & Visual Science, vol. 29, no. 11, pp. 1683–1691, 1988. View at Scopus
  46. N. M. Sawtell, “Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation,” Journal of Virology, vol. 77, no. 7, pp. 4127–4138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. G. C. Perng, E. C. Dunkel, P. A. Geary et al., “The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency,” Journal of Virology, vol. 68, no. 12, pp. 8045–8055, 1994. View at Scopus
  48. G. C. Perng, D. Esmaili, S. M. Slanina et al., “Three herpes simplex virus type 1 latency-associated transcript mutants with distinct and asymmetric effects on virulence in mice compared with rabbits,” Journal of Virology, vol. 75, no. 19, pp. 9018–9028, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. S. D. Cook, M. J. Paveloff, J. J. Doucet, A. J. Cottingham, F. Sedarati, and J. M. Hill, “Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants,” Investigative Ophthalmology & Visual Science, vol. 32, no. 5, pp. 1558–1561, 1991. View at Scopus
  50. D. M. Neumann, P. S. Bhattacharjee, N. V. Giordani, D. C. Bloom, and J. M. Hill, “In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment,” Journal of Virology, vol. 81, no. 23, pp. 13248–13253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. D. M. Neumann, P. S. Bhattacharjee, and J. M. Hill, “Sodium butyrate: a chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model,” Journal of Virology, vol. 81, no. 11, pp. 6106–6110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Clement, P. S. Bhattacharjee, M. Kumar, H. W. Thompson, J. M. Hill, and T. P. Foster, “Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus,” Investigative Ophthalmology & Visual Science, vol. 52, no. 3, pp. 1770–1779, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. N. M. Sawtell and R. L. Thompson, “Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia,” Journal of Virology, vol. 66, no. 4, pp. 2150–2156, 1992. View at Scopus
  54. C. Clement, P. S. Bhattacharjee, H. E. Kaufman, and J. M. Hill, “Heat-induced reactivation of HSV-1 in latent mice: upregulation in the TG of CD83 and other immune response genes and their LAT-ICP0 locus,” Investigative Ophthalmology & Visual Science, vol. 50, no. 6, pp. 2855–2861, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. H. E. Kaufman, E. D. Varnell, and H. W. Thompson, “Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit,” American Journal of Ophthalmology, vol. 127, no. 5, pp. 531–536, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. B. M. Gebhardt, E. D. Varnell, and H. E. Kaufman, “Acetylsalicylic acid reduces viral shedding induced by thermal stress,” Current Eye Research, vol. 29, no. 2-3, pp. 119–125, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. M. E. Marquart, X. Zheng, R. K. Tran, H. W. Thompson, D. C. Bloom, and J. M. Hill, “A cAMP response element within the latency-associated transcript promoter of HSV-1 facilitates induced ocular reactivation in a mouse hyperthermia model,” Virology, vol. 284, no. 1, pp. 62–69, 2001. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Higaki, K. Watanabe, M. Itahashi, and Y. Shimomura, “Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model,” Current Eye Research, vol. 34, no. 3, pp. 171–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. L. Corey, A. Wald, R. Patel et al., “Once-daily valacyclovir to reduce the risk of transmission of genital herpes,” The New England Journal of Medicine, vol. 350, no. 1, pp. 11–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. J. T. Schiffer, A. Magaret, S. Selke, L. Corey, and A. Wald, “Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 11, pp. 2593–2600, 2011. View at Publisher · View at Google Scholar
  61. B. M. Gebhardt, H. E. Kaufman, and J. M. Hill, “Effect of acyclovir on thermal stress-induced herpesvirus reactivation,” Current Eye Research, vol. 29, no. 2-3, pp. 137–144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. B. M. Gebhardt and H. E. Kaufman, “Propranolol suppresses reactivation of herpesvirus,” Antiviral Research, vol. 27, no. 3, pp. 255–261, 1995. View at Publisher · View at Google Scholar · View at Scopus
  63. A. B. Nesburn, M. L. Cook, and J. G. Stevens, “Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection,” Archives of Ophthalmology, vol. 88, no. 4, pp. 412–417, 1972. View at Scopus
  64. D. C. Bloom, J. G. Stevens, J. M. Hill, and R. K. Tran, “Mutagenesis of a cAMP response element within the latency-associated transcript promoter of HSV-1 reduces adrenergic reactivation,” Virology, vol. 236, no. 1, pp. 202–207, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. G. C. Perng, S. M. Slanina, A. Yukht, H. Ghiasi, A. B. Nesburn, and S. L. Wechsler, “The latency-associated transcript gene enhances establishment of herpes simplex virus type 1 latency in rabbits,” Journal of Virology, vol. 74, no. 4, pp. 1885–1891, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Clement, M. P. Popp, D. C. Bloom et al., “Microarray analysis of host gene expression for comparison between naïve and HSV-1 latent rabbit trigeminal ganglia,” Molecular Vision, vol. 14, pp. 1209–1221, 2008. View at Scopus
  67. P. R. Laibson and S. Kibrick, “Recurrence of herpes simplex virus in rabbit eyes: results of a three-year study,” Investigative ophthalmology, vol. 8, no. 3, pp. 346–350, 1969. View at Scopus
  68. A. B. Nesburn, J. H. Elliott, and H. M. Leibowitz, “Spontaneous reactivation of experimental herpes simplex keratitis in rabbits,” Archives of Ophthalmology, vol. 78, no. 4, pp. 523–529, 1967. View at Scopus
  69. H. E. Kaufman and C. Heidelberger, “Therapeutic antiviral action of 5-trifluoromethyl-2′-deoxyuridine in herpes simplex keratitis,” Science, vol. 145, no. 3632, pp. 585–586, 1964. View at Scopus
  70. H. E. Kaufman, “The first effective antiviral,” in The Search for Antiviral Drugs, J. Adams and V. J. Merluzzi, Eds., pp. 1–21, Birkhauser, Boston, Mass, USA, 1993.
  71. Y. Shimomura, L. P. Gangarosa Sr., M. Kataoka, and J. M. Hill, “HSV-1 shedding by iontophoresis of 6-hydroxydopamine followed by topical epinephrine,” Investigative Ophthalmology & Visual Science, vol. 24, no. 12, pp. 1588–1594, 1983. View at Scopus
  72. J. M. Hill, Y. Shimomura, B. S. Kwon, and L. P. Gangarosa Sr., “Iontophoresis of epinephrine isomers to rabbit eyes induced HSV-1 ocular shedding,” Investigative Ophthalmology & Visual Science, vol. 26, no. 9, pp. 1299–1303, 1985. View at Scopus
  73. B. S. Kwon, L. P. Gangarosa, K. Green, and J. M. Hill, “Kinetics of ocular herpes simplex virus shedding induced by epinephrine iontophoresis,” Investigative Ophthalmology & Visual Science, vol. 22, no. 6, pp. 818–821, 1982. View at Scopus
  74. J. M. Hill, B. S. Kwon, Y. Shimomura, G. L. Colborn, F. Yaghmai, and L. P. Gangarosa, “Herpes simplex virus recovery in neural tissues after ocular HSV shedding induced by epinephrine iontophoresis to the rabbit cornea,” Investigative Ophthalmology & Visual Science, vol. 24, no. 2, pp. 243–247, 1983. View at Scopus
  75. P. R. Laibson and S. Kibrick, “Reactivation of herpetic keratitis by epinephrine in rabbit,” Archives of Ophthalmology, vol. 75, no. 2, pp. 254–260, 1966. View at Scopus
  76. P. R. Laibson and S. Kibrick, “Reactivation of herpetic keratitis in rabbit. II. Repeated reactivations in the same host,” Archives of Ophthalmology, vol. 77, no. 2, pp. 244–248, 1967. View at Scopus
  77. A. B. Nesburn, M. T. Green, M. Radnoti, and B. Walker, “Reliable in vivo model for latent herpes simplex virus reactivation with peripheral virus shedding,” Infection and Immunity, vol. 15, no. 3, pp. 772–775, 1977. View at Scopus
  78. A. B. Nesburn, R. Dickinson, and M. Radnoti, “The effect of trigeminal nerve and ganglion manipulation on recurrence of ocular herpes simplex in rabbits,” Investigative Ophthalmology, vol. 15, no. 9, pp. 726–731, 1976. View at Scopus
  79. M. Green, J. Rosborough, and E. Dunkel, “In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model,” Infection and Immunity, vol. 34, no. 1, pp. 69–74, 1981. View at Scopus
  80. H. E. Kaufman, E. D. Varnell, B. M. Gebhardt, H. W. Thompson, and J. M. Hill, “Propanolol suppression of ocular HSV-1 recurrence and associated corneal lesions following spontaneous reactivation in the rabbit,” Current Eye Research, vol. 15, no. 6, pp. 680–684, 1996. View at Scopus
  81. J. M. Hill, Y. Shimomura, J. B. Dudley, et al., “Timolol induces HSV-1 ocular shedding in the latently infected rabbit,” Investigative Ophthalmology & Visual Science, vol. 28, no. 3, pp. 585–590, 1987. View at Scopus
  82. H. H. Garza Jr. and J. M. Hill, “Effect of a beta-adrenergic antagonist, propranolol, on induced HSV-1 ocular recurrence in latently infected rabbits,” Current Eye Research, vol. 16, no. 5, pp. 453–458, 1997. View at Publisher · View at Google Scholar · View at Scopus
  83. C. F. Beyer, M. Q. Arens, J. M. Hill, B. T. Rose, G. A. Hill, and D. T. C. Lin, “Penetrating keratoplasty in rabbits induces latent HSV-1 reactivation when corticosteroids are used,” Current Eye Research, vol. 8, no. 12, pp. 1323–1329, 1989. View at Scopus
  84. C. F. Beyer, J. M. Hill, J. Reidy, and R. W. Beuerman, “Corneal nerve disruption reactivates virus in rabbits latently infected with HSV-1,” Investigative Ophthalmology & Visual Science, vol. 31, no. 5, pp. 925–932, 1990. View at Scopus
  85. C. F. Beyer, D. J. Tepper, and J. M. Hill, “Cryogenic induced ocular HSV-1 reactivation is enhanced by an inhibitor of the lipoxygenase pathway,” Current Eye Research, vol. 8, no. 12, pp. 1287–1292, 1989. View at Scopus
  86. M. E. Myles, C. Alack, P. M. Manino et al., “Nicotine applied by transdermal patch induced HSV-1 reactivation and ocular shedding in latently infected rabbits,” Journal of Ocular Pharmacology and Therapeutics, vol. 19, no. 2, pp. 121–133, 2003. View at Scopus
  87. J. M. Hill, H. H. Garza, M. F. Helmy et al., “Nerve growth factor antibody stimulates reactivation of ocular herpes simplex virus type 1 in latently infected rabbits,” Journal of NeuroVirology, vol. 3, no. 3, pp. 206–211, 1997. View at Scopus
  88. Y. Haruta, D. S. Rootman, L. Xie, A. Kiritoshi, and J. M. Hill, “Recurrent HSV-1 corneal lesions in rabbits induced by cyclophosphamide and dexamethasone,” Investigative Ophthalmology & Visual Science, vol. 30, no. 3, pp. 371–376, 1989. View at Scopus
  89. M. E. Myles, A. Azcuy, N. T. Nguyen et al., “Bupropion (Zyban, Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits,” Journal of Pharmacology and Experimental Therapeutics, vol. 311, no. 2, pp. 640–644, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. J. Gordon, E. Romanowski, J. Harwick, J. Berman, L. Olsakovsky, and T. Araullo-Cruz, “The effect of alpha blockade on iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals,” Current Eye Research, vol. 9, no. 10, pp. 1007–1014, 1990. View at Scopus
  91. J. M. Hill, R. Wen, and W. P. Halford, “Pathogenesis and molecular biology of ocular HSV in the rabbit,” in Herpes simplex Virus Protocols, M. S. Brown and A. R. MacLean, Eds., pp. 291–315, Humana Press, 1998.
  92. B. A. Richardson and J. Overbaugh, “Basic statistical considerations in virological experiments,” Journal of Virology, vol. 79, no. 2, pp. 669–676, 2005. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Agresti, Categorical Data Analysis, Wiley, New York, NY, USA, 1990.
  94. G. Casella and R. L. Berger, Statistical Inference, Thomson Learning, Pacific Grove, Calif, USA, 2002.
  95. R. A. Fisher, “On the interpretation of x2 from contingency tables, and the calculations of P,” Journal of Royal Statistical Society, vol. 85, no. 1, pp. 87–94, 1922. View at Publisher · View at Google Scholar
  96. A. Agresti, “A survey of exact inference for contingency tables,” Statistical Science, vol. 7, no. 1, pp. 131–153, 1992. View at Publisher · View at Google Scholar
  97. R. Mera, H. W. Thompson, and C. Prasad, “Analysis of data that is in the form of categories: Part I: Interpretation, Chi-square, odds ratio and sample size,” Nutritional Neuroscience, vol. 2, no. 5, pp. 369–374, 1999. View at Scopus
  98. R. Mera, H. W. Thompson, and C. Prasad, “Analysis of data that is in the form of categories Part II: Beyond the 2*2 contingency table -partitioning Chi-square tests,” Nutritional Neuroscience, vol. 3, no. 2, pp. 143–149, 2000. View at Scopus
  99. P. McCullagh and J. A. Nelder, Generalized Linear Models, Chapman and Hall, New York, NY, USA, 1989.
  100. K. Y. Liang and S. L. Zeger, “Longitudinal data analysis using generalized linear models,” Biometrika, vol. 73, no. 1, pp. 13–22, 1986. View at Publisher · View at Google Scholar · View at Scopus
  101. E. Demidenko, Mixed Models: Theory and Applications, Wiley-Interscience, Hoboken, NJ, USA, 2004.
  102. W. P. Halford, B. M. Gebhardt, and D. J. J. Carr, “Mechanisms of herpes simplex virus type 1 reactivation,” Journal of Virology, vol. 70, no. 8, pp. 5051–5060, 1996. View at Scopus
  103. T. J. Pasieka, L. Collins, M. A. O'Connor et al., “Bioluminescent imaging reveals divergent viral pathogenesis in two strains of Stat1-deficient mice, and in αβγ interferon receptor-deficient mice,” PLoS ONE, vol. 6, no. 9, Article ID e24018, 2011. View at Publisher · View at Google Scholar
  104. M. P. Vitek, C. M. Brown, and C. A. Colton, “APOE genotype-specific differences in the innate immune response,” Neurobiology of Aging, vol. 30, no. 9, pp. 1350–1360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. T. J. Pasieka, B. Lu, and D. A. Leib, “Enhanced pathogenesis of an attenuated herpes simplex virus for mice lacking Stat1,” Journal of Virology, vol. 82, no. 12, pp. 6052–6055, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. B. Kim, P. P. Sarangi, A. K. Azkur, S. D. Kaistha, and B. T. Rouse, “Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses,” Microbes and Infection, vol. 10, no. 3, pp. 302–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. D. J. Lenschow, C. Lai, N. Frias-Staheli et al., “IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 4, pp. 1371–1376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. K. Banerjee, P. S. Biswas, and B. T. Rouse, “Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis,” Journal of Interferon and Cytokine Research, vol. 27, no. 1, pp. 65–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. P. S. Biswas, K. Banerjee, B. Kim, and B. T. Rouse, “Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis,” Journal of Immunology, vol. 172, no. 6, pp. 3736–3744, 2004. View at Scopus
  110. W. P. Halford, C. Weisend, J. Grace et al., “ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency,” Virology Journal, vol. 3, article 44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. S. D. Haenchen, J. A. Utter, A. M. Bayless, R. T. Dobrowsky, and D. J. Davido, “Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo,” Journal of NeuroVirology, vol. 16, no. 5, pp. 405–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. K. A. Laycock, S. F. Lee, R. H. Brady, and J. S. Pepose, “Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation,” Investigative Ophthalmology & Visual Science, vol. 32, no. 10, pp. 2741–2746, 1991. View at Scopus
  113. J. M. Pesola, J. Zhu, D. M. Knipe, and D. M. Coen, “Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production,” Journal of Virology, vol. 79, no. 23, pp. 14516–14525, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. J. D. Kriesel, B. M. Gebhardt, J. M. Hill et al., “Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation,” Journal of Infectious Diseases, vol. 175, no. 4, pp. 821–827, 1997. View at Scopus
  115. B. M. Gebhardt, E. D. Varnell, and H. E. Kaufman, “Inhibition of cyclooxygenase 2 synthesis suppresses herpes simplex virus type 1 reactivation,” Journal of Ocular Pharmacology and Therapeutics, vol. 21, no. 2, pp. 114–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. J. M. Hill, Y. Haruta, and D. S. Rootman, “Adrenergically induced recurrent HSV-1 corneal epithelial lesions,” Current Eye Research, vol. 6, no. 8, pp. 1065–1071, 1987. View at Scopus
  117. Y. Haruta, D. S. Rootman, and J. M. Hill, “Recurrent HSV-1 corneal epithelial lesions induced by timolol iontophoresis in latently infected rabbits,” Investigative Ophthalmology & Visual Science, vol. 29, no. 3, pp. 387–392, 1988. View at Scopus